Discover · The Research Behind It
Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis — Lynch et al., Addiction 2020
Last checked
- Free
- Worldwide
- Research paper
- Reading
- Online
Never stop or reduce a prescribed medicine on your own: some medicines cause withdrawal effects or a relapse if they are stopped or cut down too quickly. Use these resources to plan it with your prescriber.
- Published in
- Addiction, 2020
- Evidence
- Moderate
- Cost
- Free.
What is this paper about?
Pooled 8 randomised trials (2,071 patients) of brief primary-care interventions for people taking benzodiazepines or Z-drugs for three months or more, mostly letters signed by the prescriber or a pharmacist, sometimes with a booklet, or a short consultation with a GP, pharmacist or nurse. Stopping was about 2.7 times as likely as with usual care at six months (RR 2.73, 95% CI 1.84–4.06) and about 3.4 times as likely at 12 months (2 trials).
Why is it in the directory?
Backs up deprescribing.org, the Canadian Deprescribing Network and the Benzodiazepine Information Coalition in chapter 06: clear information and a prompt from a trusted clinician can help people come off sleeping pills and tranquillisers.
Is it free to read?
Systematic review and meta-analysis — 8 randomised trials, 2,071 patients. Moderate evidence. Addiction 2020;115(9):1618–1639. DOI 10.1111/add.14981. Free full text in PubMed Central (PMC7891570) — open access, CC BY-NC 4.0.
About the paper
- Authors
- Lynch T, Ryan C, Hughes CM, et al.
- Published in
- Addiction 2020;115(9):1618–1639
- Kind of study
- Systematic review and meta-analysis — 8 randomised trials, 2,071 patients
- Strength of evidence
- Moderate — good studies, but fewer of them or with some limits
- Free to read
- CC BY-NC 4.0
Good to know
- Only two of the eight trials were at low risk of bias in most areas, results varied between trials (I² 55%) and few included Z-drug users.
Where it sits in the directory
Listed under “Coming Off Medication Safely — Tapering & Deprescribing” in chapter 17 of the directory, The Research Behind It, with 12 other listings in the same category.
Similar listings
Also in the directory, with why each one is here.
- Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline — Pottie et al., Can Fam Physician 2018
Also a free research paper available worldwide, also for clinicians, in the same category.
This deprescribing.org guideline recommends offering a slow taper to adults aged 65 or over who take benzodiazepines or Z-drugs for insomnia, whatever the duration of…
- Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults — NICE 2022
Also a free research paper available worldwide, also for clinicians, in the same category.
NICE's guideline on withdrawing opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants.
- Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline — Bjerre et al., Can Fam Physician 2018
Also a free research paper available worldwide, also for clinicians, in the same category.
Guideline from the deprescribing.org team, built with GRADE methods, a Cochrane review of antipsychotic withdrawal trials in dementia and a systematic review for…
- Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis — Henssler et al., Lancet Psychiatry 2024
Also a free research paper available worldwide, also for clinicians, in the same category.
Pooled 79 studies (21,002 people) in which an antidepressant or placebo was stopped.
- Say Good Night to Insomnia: The Six-Week, Drug-Free Program Developed at Harvard Medical School — Gregg D. Jacobs PhD (book & audiobook; Conquering Insomnia online program)
A guide or book available worldwide, listed under “Sleep” in Self-Help Library.
The original self-help version of cognitive behavioural therapy for insomnia (CBT-I), the first-line treatment in every major guideline, as a six-week programme: sleep…
- Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial — Kyle et al., Lancet 2023
Also a free research paper available worldwide, also for clinicians, listed under “Sleep” in the same chapter.
Practice nurses gave four brief sessions of sleep restriction therapy (a core part of CBT-I) plus a sleep-hygiene booklet, compared with the booklet alone.
This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.